GnRH-a for Ovarian Protection During CYC Therapy for Rheumatic Diseases

NCT01257802 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Lupus Erythematosus, Systemic
Systemic Vasculitis
Isolated Angiitis of Central Nervous System
Lung Disease With Systemic Sclerosis
Lung Disease Interstitial Diffuse

Interventions

DRUG: depot leuprolide acetate 3.75 mg
DRUG: Placebo

Sponsor

Joseph Mccune

Collaborators

[object Object]
[object Object]